Icos Capital
 
HOME ABOUT US FOCUS TEAM INVESTMENTS NEWS
 
NEWS MEDIA COVERAGE

PRESS RELEASE

(07/2011)
BIOACTOR B.V. closes Series A financing round to fund growth strategy
BIOACTOR B.V. finaliseert een eerste financieringsronde om haar groeistrategie te financieren

(03/2011)
DSM to develop and manufacture Ferritin for BiAqua B.V. global water contamination studies
Biaqua Ferritin validated for its adsorption capacity to remove > 99.95% of 32P (i.e. < 1 ppb)

(09/2010)
Icos Capital announces first closing of a cleantech fund in partnership with BAM, CSM, Imtech and Delft University of Technology (DUT)
Icos Capital, BAM, CSM, Imtech en TU DELFT geven nieuwe impuls aan cleantech innovaties

(09/2009)
Icos Capital invests in TU Delft water spin-off

(09/2008)
Icos Capital finances revolutionary rapid food safety detection technology

(08/2008)
Fred van Efferink joins EVCA Board (News release by EVCA)
Icos Capital invests in TU Delft technology spin-out

(06/2008)
Ensartech secures strategic investment to rollout new waste to energy conversion technology

(03/2008)
Icos Capital invests in unique air-to-water technology

(01/2008)
Icos Capital taps into Russian innovations in energy markets

(12/2007)
New general partner strengthens Icos Capital investment team
Key trends and technologies for next generation energy markets revealed at Icos business conference

(10/2007)
Icos Capital Finances Technology in Energy Conversion
Icos Capital financiert technologie in conversie van energie

(07/2007)
Icos Capital appoints Director Investor Relations
Icos Capital versterkt Investor Relations

(08/2006)
Dutch Technology Fund I ranked first by TechnoPartner
Dutch Technology Fund I als eerste geeïndigd bij TechnoPartnerIcos Capital announces first closing of a cleantech fund in partnership with BAM, CSM, Imtech and Delft University of Technology (DUT)
Icos Capital, BAM, CSM, Imtech en TU DELFT geven nieuwe impuls aan cleantech innovaties

 
FAQ   |   SITEMAP   |   CONTACT US
© copy right reserved 2011